Operating Expenses: The sum of all operating expenses for the given industry.
Beam Therapeutics Inc. (BEAM) had Operating Expenses of $127.04M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
$0.49M |
|
$-122.68M |
|
-- |
|
$0.49M |
|
|
Operating Expenses |
$127.04M |
$-126.55M |
|
$3.88M |
|
$-122.68M |
|
$-122.68M |
|
$-122.68M |
|
$-122.68M |
|
$-122.68M |
|
$-122.68M |
|
$-126.55M |
|
$-123.68M |
|
104.33M |
|
104.33M |
|
$-1.18 |
|
$-1.18 |
|
| Balance Sheet Financials | |
$1.18B |
|
$97.61M |
|
$207.76M |
|
$1.39B |
|
$80.88M |
|
$100.26M |
|
$238.03M |
|
$318.91M |
|
$1.07B |
|
$1.07B |
|
$1.07B |
|
103.27M |
|
| Cash Flow Statement Financials | |
$-194.61M |
|
$15.39M |
|
$104.13M |
|
$301.62M |
|
$226.54M |
|
$-75.08M |
|
$38.32M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
14.57 |
|
-- |
|
-- |
|
0.09 |
|
0.09 |
|
100.00% |
|
-25827.14% |
|
-25827.14% |
|
-- |
|
-25036.33% |
|
-25036.33% |
|
$-199.25M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
-- |
|
-- |
|
-- |
|
-11.49% |
|
-11.49% |
|
-8.85% |
|
-10.51% |
|
$10.34 |
|
$-1.91 |
|
$-1.87 |
|